{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T00:06:53Z","timestamp":1755907613624,"version":"3.44.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,22]]},"DOI":"10.7759\/cureus.90729","type":"journal-article","created":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T10:57:18Z","timestamp":1755860238000},"source":"Crossref","is-referenced-by-count":0,"title":["A Challenging Diagnosis of Laryngeal Neuroendocrine Tumor (NET): Final Classification as NET Grade 3 After Total Laryngectomy"],"prefix":"10.7759","author":[{"given":"Naoya","family":"Sanda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nayuta","family":"Tsushima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hayato","family":"Imanari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Homma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.21147\/j.issn.1000-9604.2020.01.03","article-title":"Updates on larynx cancer epidemiology","volume":"32","author":"Nocini R","year":"2020","unstructured":"Nocini R, Molteni G, Mattiuzzi C, Lippi G. Updates on larynx cancer epidemiology. Chin J Cancer Res. 2020, 32:18-25. 10.21147\/j.issn.1000-9604.2020.01.03","journal-title":"Chin J Cancer Res"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2006.01.002","article-title":"Neuroendocrine neoplasms of the larynx: advances in identification, understanding, and management","volume":"42","author":"Ferlito A","year":"2006","unstructured":"Ferlito A, Devaney KO, Rinaldo A. Neuroendocrine neoplasms of the larynx: advances in identification, understanding, and management. Oral Oncol. 2006, 42:770-88. 10.1016\/j.oraloncology.2006.01.002","journal-title":"Oral Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2010.166","article-title":"The origin of neuroendocrine tumors and the neural crest saga","volume":"24 Suppl 2","author":"Rosai J","year":"2011","unstructured":"Rosai J. The origin of neuroendocrine tumors and the neural crest saga. Mod Pathol. 2011, 24 Suppl 2:S53-7. 10.1038\/modpathol.2010.166","journal-title":"Mod Pathol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12155138","article-title":"A comprehensive review on neuroendocrine neoplasms: presentation, pathophysiology and management","volume":"12","author":"Sultana Q","year":"2023","unstructured":"Sultana Q, Kar J, Verma A, et al.. A comprehensive review on neuroendocrine neoplasms: presentation, pathophysiology and management. J Clin Med. 2023, 12:10.3390\/jcm12155138","journal-title":"J Clin Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s11154-020-09612-2","article-title":"Classification of neuroendocrine neoplasms: lights and shadows","volume":"22","author":"La Rosa S","year":"2021","unstructured":"La Rosa S, Uccella S. Classification of neuroendocrine neoplasms: lights and shadows. Rev Endocr Metab Disord. 2021, 22:527-38. 10.1007\/s11154-020-09612-2","journal-title":"Rev Endocr Metab Disord"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s12105-022-01435-8","article-title":"Update from the 5th edition of the World Health Organization classification of head and neck tumors: overview of the 2022 WHO classification of head and neck neuroendocrine neoplasms","volume":"16","author":"Mete O","year":"2022","unstructured":"Mete O, Wenig BM. Update from the 5th edition of the World Health Organization classification of head and neck tumors: overview of the 2022 WHO classification of head and neck neuroendocrine neoplasms. Head Neck Pathol. 2022, 16:123-42. 10.1007\/s12105-022-01435-8","journal-title":"Head Neck Pathol"},{"key":"ref7","doi-asserted-by":"crossref","DOI":"10.1002\/hed.23666","article-title":"Clinical recommendations on the treatment of neuroendocrine carcinoma of the larynx: a meta-analysis of 436 reported cases","volume":"37","author":"van der Laan TP","year":"2015","unstructured":"van der Laan TP, Plaat BE, van der Laan BF, Halmos GB. Clinical recommendations on the treatment of neuroendocrine carcinoma of the larynx: a meta-analysis of 436 reported cases. Head Neck. 2015, 37:707-15.","journal-title":"Head Neck"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s12105-018-0894-6","article-title":"Neuroendocrine carcinomas of the larynx and head and neck: challenges in classification and grading","volume":"12","author":"Perez-Ordo\u00f1ez B","year":"2018","unstructured":"Perez-Ordo\u00f1ez B. Neuroendocrine carcinomas of the larynx and head and neck: challenges in classification and grading. Head Neck Pathol. 2018, 12:1-8. 10.1007\/s12105-018-0894-6","journal-title":"Head Neck Pathol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2022.111726","article-title":"Synaptophysin and chromogranin A expression analysis in human tumors","volume":"555","author":"Uhlig R","year":"2022","unstructured":"Uhlig R, Dum D, Gorbokon N, et al.. Synaptophysin and chromogranin A expression analysis in human tumors. Mol Cell Endocrinol. 2022, 555:111726. 10.1016\/j.mce.2022.111726","journal-title":"Mol Cell Endocrinol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.21037\/atm.2018.06.27","article-title":"Histopathological, immunohistochemical, genetic and molecular markers of neuroendocrine neoplasms","volume":"6","author":"Kyriakopoulos G","year":"2018","unstructured":"Kyriakopoulos G, Mavroeidi V, Chatzellis E, Kaltsas GA, Alexandraki KI. Histopathological, immunohistochemical, genetic and molecular markers of neuroendocrine neoplasms. Ann Transl Med. 2018, 6:252. 10.21037\/atm.2018.06.27","journal-title":"Ann Transl Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000001037","article-title":"INSM1 is a sensitive and specific marker of neuroendocrine differentiation in head and neck tumors","volume":"42","author":"Rooper LM","year":"2018","unstructured":"Rooper LM, Bishop JA, Westra WH. INSM1 is a sensitive and specific marker of neuroendocrine differentiation in head and neck tumors. Am J Surg Pathol. 2018, 42:665-71. 10.1097\/PAS.0000000000001037","journal-title":"Am J Surg Pathol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13194813","article-title":"Neuroendocrine carcinoma of the larynx and pharynx: a clinical and histopathological study","volume":"13","author":"Strojan P","year":"2021","unstructured":"Strojan P, \u0160ifrer R, Ferlito A, Gra\u0161i\u010d-Kuhar C, Lani\u0161nik B, Plavc G, Zidar N. Neuroendocrine carcinoma of the larynx and pharynx: a clinical and histopathological study. Cancers (Basel). 2021, 13:10.3390\/cancers13194813","journal-title":"Cancers (Basel)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e318236d822","article-title":"Head and neck large cell neuroendocrine carcinoma should be separated from atypical carcinoid on the basis of different clinical features, overall survival, and pathogenesis","volume":"36","author":"Kao HL","year":"2012","unstructured":"Kao HL, Chang WC, Li WY, Chia-Heng Li A, Fen-Yau Li A. Head and neck large cell neuroendocrine carcinoma should be separated from atypical carcinoid on the basis of different clinical features, overall survival, and pathogenesis. Am J Surg Pathol. 2012, 36:185-92. 10.1097\/PAS.0b013e318236d822","journal-title":"Am J Surg Pathol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s12105-021-01367-9","article-title":"Neuroendocrine neoplasms of the larynx: a clinicopathologic analysis of 27 neuroendocrine tumors and neuroendocrine carcinomas","volume":"16","author":"Bal M","year":"2022","unstructured":"Bal M, Sharma A, Rane SU, Mittal N, Chaukar D, Prabhash K, Patil A. Neuroendocrine neoplasms of the larynx: a clinicopathologic analysis of 27 neuroendocrine tumors and neuroendocrine carcinomas. Head Neck Pathol. 2022, 16:375-87. 10.1007\/s12105-021-01367-9","journal-title":"Head Neck Pathol"},{"key":"ref15","doi-asserted-by":"crossref","DOI":"10.15403\/jgld-4654","article-title":"NET G3 vs NEC: p53 and Rb1 immunolabeling in high-grade gastrointestinal neuroendocrine neoplasms - is it enough for the differential diagnosis?","volume":"32","author":"Dinu A","year":"2023","unstructured":"Dinu A, Aschie M, Cozaru GC, et al.. NET G3 vs NEC: p53 and Rb1 immunolabeling in high-grade gastrointestinal neuroendocrine neoplasms - is it enough for the differential diagnosis?. J Gastrointestin Liver Dis. 2023, 32:162-9.","journal-title":"J Gastrointestin Liver Dis"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-024-04006-0","article-title":"Diagnostic relevance of p53 and Rb status in neuroendocrine tumors G3 from different organs: an immunohistochemical study of 465 high-grade neuroendocrine neoplasms","volume":"486","author":"Kanaan C","year":"2025","unstructured":"Kanaan C, Bani MA, Ducreux M, et al.. Diagnostic relevance of p53 and Rb status in neuroendocrine tumors G3 from different organs: an immunohistochemical study of 465 high-grade neuroendocrine neoplasms. Virchows Arch. 2025, 486:941-50. 10.1007\/s00428-024-04006-0","journal-title":"Virchows Arch"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1177\/01455613231155853","article-title":"Clinical diagnosis and treatment of primary laryngeal neuroendocrine carcinoma","author":"Wang Y","year":"2023","unstructured":"Wang Y, Liu D, She C. Clinical diagnosis and treatment of primary laryngeal neuroendocrine carcinoma. Ear Nose Throat J. 2023, 1455613231155853. 10.1177\/01455613231155853","journal-title":"Ear Nose Throat J"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijscr.2024.110657","article-title":"G2 neuroendocrine tumors of the larynx: a case report","volume":"125","author":"Yang T","year":"2024","unstructured":"Yang T, Xiao L, Ren H. G2 neuroendocrine tumors of the larynx: a case report. Int J Surg Case Rep. 2024, 125:110657. 10.1016\/j.ijscr.2024.110657","journal-title":"Int J Surg Case Rep"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000038382","article-title":"Giant laryngeal neuroendocrine neoplasm causing airway obstruction: a case report and literature review","volume":"103","author":"Wang Y","year":"2024","unstructured":"Wang Y, Ding L, Liu J, et al.. Giant laryngeal neuroendocrine neoplasm causing airway obstruction: a case report and literature review. Medicine (Baltimore). 2024, 103:e38382. 10.1097\/MD.0000000000038382","journal-title":"Medicine (Baltimore)"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijscr.2024.110356","article-title":"Horizontal partial laryngectomy for laryngeal neuroendocrine tumor: a case report","volume":"124","author":"Kashima K","year":"2024","unstructured":"Kashima K, Igarashi T, Fujii H, Fukushima N, Nishino H, Kanazawa T. Horizontal partial laryngectomy for laryngeal neuroendocrine tumor: a case report. Int J Surg Case Rep. 2024, 124:110356. 10.1016\/j.ijscr.2024.110356","journal-title":"Int J Surg Case Rep"},{"key":"ref21","article-title":"","year":"2024","unstructured":"TNM Classification of Malignant Tumours, 8th Edition. Union for International Cancer Control, Geneva, Switzerland; 2024. https.\/\/www.uicc.org\/resources\/tnm-classification-malignant-tumours-8th-edition."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/402085-a-challenging-diagnosis-of-laryngeal-neuroendocrine-tumor-net-final-classification-as-net-grade-3-after-total-laryngectomy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T10:57:19Z","timestamp":1755860239000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/402085-a-challenging-diagnosis-of-laryngeal-neuroendocrine-tumor-net-final-classification-as-net-grade-3-after-total-laryngectomy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,22]]},"references-count":21,"URL":"https:\/\/doi.org\/10.7759\/cureus.90729","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,22]]}}}